Mark Pearson

Mark Pearson is an accomplished professional in business development and account management within the pharmaceutical and fine chemicals industries. Currently serving as Senior Director of Business Development and Key Account Manager at Siegfried since June 2023, Mark focuses on managing key accounts and driving business growth for the Siegfried Drug Substance Exclusives Business in Europe. Prior experience includes a tenure as Senior Director of Business Development at STA Pharmaceutical, where Mark contributed to efficient development and manufacturing solutions for small molecule APIs. Mark also held the Director of Business Development position at Dr. Reddy's Laboratories, overseeing PEGylation drug delivery technology and new business acquisition. Additional experience encompasses roles at Dow Chemicals, Lonza, and Albright & Wilson, showcasing a diverse background in strategy, sales, and marketing across various chemical and pharmaceutical sectors. Mark holds a DPhil, MA, and BA in Chemistry from the University of Oxford, complemented by secondary education at The Manchester Grammar School.